Company Filing History:
Years Active: 2008-2011
Title: Boran Altincicek: Innovator in Biochemical Pathways
Introduction
Boran Altincicek is a prominent inventor based in Fernwald-Annerod, Germany. He has made significant contributions to the field of biochemistry, particularly in the area of isoprenoid biosynthesis and T-cell activation. With a total of three patents to his name, Altincicek's work has the potential to impact both medical and agricultural sectors.
Latest Patents
One of Altincicek's latest patents focuses on the inactivation of genes of the MEP pathway. This invention relates to cells and organisms, as well as methods for producing these cells and organisms. The process involves enriching intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis by deleting or inactivating specific genes. Additionally, the derivatives can be enriched using enzyme inhibitors, making them useful as substrates in enzyme activity tests. The inventive cells and organisms, along with the enriched intermediates, can further be utilized in the production of medicaments.
Another significant patent by Altincicek involves organophosphorous compounds for the activation of gamma/delta T cells. This invention describes organophosphorus compounds of a general formula, their preparation, and their applications in activating gamma/delta T-cells. It also includes their use in screening GcpE and LytB enzyme inhibitors, as well as in the prophylaxis and treatment of diseases in both humans and animals.
Career Highlights
Boran Altincicek is currently associated with Bioagency AG, where he continues to innovate and develop new biochemical solutions. His work has garnered attention for its potential applications in various fields, including medicine and biotechnology.
Collaborations
Altincicek collaborates with notable colleagues such as Hassan Jomaa and Oliver Wolf. Their combined expertise enhances the research and development efforts at Bioagency AG.
Conclusion
Boran Altincicek is a distinguished inventor whose work in biochemical pathways is paving the way for advancements in medical treatments and agricultural applications. His innovative patents reflect a commitment to improving health outcomes and enhancing scientific understanding.